Howard is an accomplished entrepreneur in the life sciences industry and prior to joining Seventh Sense, he was the founder, Chairman and CEO of EKR Therapeutics, a specialty pharmaceutical company focused in the hospital critical care market. Mr. Weisman was also co-founder of ESP Pharma where he served as a director in addition to the company's President and COO until its sale to PDL Biopharma in 2005. He began his career in sales and marketing at Merck and Co, Inc. and later moved to Parke-Davis where he launched that company's diabetes franchise in 1997. Howard graduated with a BA in Chemistry from Rutgers University.
Howard is Chief Scientific Officer at Seventh Sense Biosystems. Dr. Bernstein has over 25 years of experience in technology and drug development. He has been involved in the development of eight different products including Nutropin Depot, which was the first sustained release product to be approved by the FDA. Before joining Seventh Sense, Dr. Bernstein was Executive Vice President of Research and Development at Acusphere, Inc. and prior to that, he was Vice President of Pharmaceutical Development at Alkermes. He is a member of the National Academy of Engineering and he holds 250 patents and patent applications. Dr. Bernstein received his Ph.D. in chemical engineering from MIT and his M.D. from Harvard Medical School through the MIT-Harvard Health Sciences and Technology program.
Jerry is an accomplished product development and commercialization engineer in the medical products field and joins Seventh Sense Biosystems from Vention Medical in Marlborough, MA. Throughout his career, he has had responsibility for all aspects of the product life cycle from product development to manufacturing and commercialization of new medical devices. Both a technical and business leader, Jerry has over 25 years of experience developing and marketing a wide variety of disposable medical devices and catheter based vascular devices. Prior to Vention Medical, he was Director of Catheter R&D at startup, Infraredx, Inc. where he designed, prototyped, tested, and commercialized new near infrared spectroscopy catheters to detect vulnerable plaque in coronary arteries. Jerry also worked for Medtronic AVE as an Engineering Manager and as Global Marketing Product Manager, playing a key role in product acquisitions and technology transfers. Early in his career, he led engineering and marketing efforts at Haemonetics Corporation. Jerry has a Bachelor of Science in Mechanical Engineering from Bucknell University and a MBA from Northeastern University.
Tim joined Seventh Sense Biosystems in 2013, bringing a diverse set of international experiences and expertise in general management, operations, commercial management and strategy in the medical device field. Prior to Seventh Sense, Mr. Richards held the role of President at Facet Technologies, a supplier to major diagnostic companies. Previous experience includes executive level positions at Covidien where he served as President of US Patient Care and Safety and as President of VNUS, a $440 million acquisition. Prior to this, he was the Chief Marketing Officer at B Braun Medical and he held a number of commercial and strategic leadership positions with Becton Dickinson & Company in both the US and Asia. Mr. Richards received his B.A. from Lake Forest College and has participated in executive management and organizational development programs at Stanford Business School, European School of Management and Technology and American University.